The innovation of treating without surgery
It is now known that nasal polyps may be caused by an underlying inflammation called type 2 inflammation. By inhibiting 2 key sources of type 2 inflammation, DUPIXENT is clinically proven to significantly reduce nasal congestion and shrink nasal polyps.
DUPIXENT is the first biologic FDA-approved in CRSwNP and is not an immunosuppressant or a steroid.
In clinical trials, patients with uncontrolled chronic rhinosinusitis with nasal polyposis (CRSwNP) who took DUPIXENT saw reduced nasal congestion and nasal polyp size at Week 24 and continued reduction at Week 52.
Patients taking DUPIXENT saw the following symptom relief in as little as 3 days:
Is DUPIXENT Right For You?
Patients living with uncontrolled chronic rhinosinusitis with nasal polyposis (CRSwNP) who may find relief with DUPIXENT include those who:
despite the use of systemic
or have had previous
If you have any of these characteristics,
speak to your doctor about DUPIXENT
See How DUPIXENT Can Help
The effectiveness and safety of DUPIXENT was studied in adults with uncontrolled chronic rhinosinusitis
with nasal polyps in 2 clinical trials. Find out more about the results.
HAVE A PRODUCTIVE CONVERSATION WITH YOUR DOCTOR
Our goal is for you or your loved one to get the most out of your visit to the doctor. Fill out our personalized discussion guide to help you have a productive conversation during your next visit.
FIND A SPECIALIST WHO TREATS NASAL POLYPS
Use this Healthgrades™ tool to easily find nearby specialists with experience in treating adults with uncontrolled chronic rhinosinusitis with nasal polyposis (CRSwNP).
Sanofi US and Regeneron do not endorse or recommend any particular physician, and search results do not include a comprehensive list of doctors in your area.